グルコースバイオセンサーの世界市場の規模及び予測:エンドユーザー別(病院、ホームケア診断、研究機関、診断センター、診療所)、地域別(米国、英国、ドイツ、中国、インド、ブラジル、サウジアラビア、南アフリカ)、動向分析、2015-2022...市場調査レポートについてご紹介

【英文タイトル】Glucose Biosensor Market Size & Forecast By End-use (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, Clinics), By Region (U.S., UK, Germany, China, India, Brazil, Saudi Arabia, South Africa) And Trend Analysis From 2015 To 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Glucose biosensors Market – Industry Summary and Key Buying Criteria, 2012 – 2020
Chapter 3. Glucose biosensors Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2012-2020
3.3. Glucose biosensors: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Rising prevalence of diabetes
3.3.1.2. Presence of a strong range of products in pipeline
3.3.1.3. Growing prevalence of lifestyle induced disorders such as obesity
3.3.2. Market restraint analysis
3.3.2.1. Presence of alternative methods
3.4. Glucose biosensors market: Industry trend analysis
3.5. Glucose biosensors Market – PESTEL Analysis
3.6. Glucose biosensors Industry analysis – Porter’s Five Forces Model
3.7. Glucose biosensors: Company Market Share Analysis (%), 2014
3.8. Key opportunities prioritized
Chapter 4. Glucose Biosensors End-User Application Outlook
4.1. Glucose Biosensors Revenue Share (%) Analysis, by End-User Application, 2014 & 2022
4.2. Hospital
4.2.1. Hospital market revenue, by region, 2012 to 2022 (USD Million)
4.3. Homecare Diagnostics
4.3.1. Homecare diagnostics market revenue, by region, 2012 to 2022 (USD Million)
4.4. Others
4.4.1. Others market revenue, by region, 2012 to 2022 (USD Million)
Chapter 5. Glucose Biosensors Regional Outlook
5.1. Glucose Biosensors Market Share (%) Analysis, by Region, 2014 & 2022
5.2. North America
5.2.1. U.S.
5.2.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.2.2. Canada
5.2.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.3. Europe
5.3.1. Germany
5.3.1.1. glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.3.2. U.K.
5.3.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.3.3. Rest of Europe
5.3.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.4. Asia Pacific
5.4.1. China
5.4.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.4.2. India
5.4.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.4.3. Rest of Asia Pacific
5.4.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.5. MEA
5.5.1. South Africa
5.5.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.5.2. Saudi Arabia
5.5.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.5.3. Rest of MEA
5.5.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.6.2. Mexico
5.6.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.6.3. Rest of Latin America
5.6.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
Chapter 6. Competitive Landscape
6.1. Roche Diagnostics
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. LifeScan Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Abbott Laboratories
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Bayer
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Medtronic Inc.
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Pinnacle Medical Solutions Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. AgaMatrix Inc.
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Sanofi S.A.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. BioSense Medical Devices, LLC
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Nova Biomedical
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:グルコースバイオセンサーの世界市場の規模及び予測:エンドユーザー別(病院、ホームケア診断、研究機関、診断センター、診療所)、地域別(米国、英国、ドイツ、中国、インド、ブラジル、サウジアラビア、南アフリカ)、動向分析、2015-2022
■ 英文:Glucose Biosensor Market Size & Forecast By End-use (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, Clinics), By Region (U.S., UK, Germany, China, India, Brazil, Saudi Arabia, South Africa) And Trend Analysis From 2015 To 2022
■ 発行日:2016年2月22日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707367
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。